ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Boryung Pharmaceutical Co., Ltd clinical trials

Part of Boryung Holdings Co., Ltd., which holds 50.66% as of 2026-06-10. Source

The registry lists 143 studies whose lead sponsor is Boryung Pharmaceutical Co., Ltd. 23 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.

Keep track of what changes. Save the Boryung Pharmaceutical Co., Ltd studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
118
Recruiting
16
Not yet recruiting
7
Withdrawn
1
Active, not recruiting
1

Phase

Phase 1
77
Phase 3
22
Phase 2
9
Phase 4
6
Early Phase 1
1

Where

Korea, Republic of
121
Thailand
1
United States
1
Indonesia
1

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Boryung Pharmaceutical Co., Ltd.

  • Boryung Pharmaceutical Co., Ltd
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    143 studies

Related but not counted here: ViGenCell Inc. (affiliate).

Focus areas

Conditions Boryung Pharmaceutical Co., Ltd leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Essential Hypertension46Hypertension44

Studies

Recruiting first, then most recently updated. Showing 50 of 143. Browse all 143 →